Filing search / Fate Therapeutics, Inc. / "Responsibility" / Page 4

8-K

EX-1.1

cfxz5k

12 Sep 19

Fate Therapeutics Announces Proposed Public Offering of Common Stock

9:30pm

424B5

mp4x6x300m7t3u

12 Sep 19

Prospectus supplement for primary offering

9:25pm

424B5

fsqo76 prwf6cj

11 Sep 19

Prospectus supplement for primary offering

4:08pm

8-K

5temqlufv8mc1dbr4q

17 Jul 19

Fate Therapeutics Announces the Appointment of Dr. Shefali Agarwal to its Board of Directors

4:03pm

8-K

EX-99.1

3i6q5ikrx 82535mt

17 Jul 19

Fate Therapeutics Announces the Appointment of Dr. Shefali Agarwal to its Board of Directors

4:03pm

8-K

EX-1.1

4ltnrlpefs4 16n9mt8

21 Nov 18

Entry into a Material Definitive Agreement

4:19pm

S-3ASR

EX-1.2

x5gv06zd mwiapr

21 Nov 18

Automatic shelf registration

4:06pm

S-3ASR

wusti0ig 7icx9be7p

21 Nov 18

Automatic shelf registration

4:06pm

8-K

EX-1.1

jaq6xbmez1f uhcfnex7

21 Sep 18

Fate Therapeutics Announces Proposed Public Offering of Common Stock

4:52pm

424B5

3xi2gw4zlddmpj8 xrq1

21 Sep 18

Prospectus supplement for primary offering

4:41pm